Deep vein thrombosis in a well-trained masters cyclist, is popliteal vein entrapment syndrome to blame?


Journal

Journal of thrombosis and thrombolysis
ISSN: 1573-742X
Titre abrégé: J Thromb Thrombolysis
Pays: Netherlands
ID NLM: 9502018

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 21 12 2018
medline: 18 6 2019
entrez: 21 12 2018
Statut: ppublish

Résumé

Whilst athletes are the epitome of health, venous thromboembolisms (VTE) including deep vein thrombosis and pulmonary embolism have been demonstrated to occur in well-trained athletes. VTE is frequently misdiagnosed and poorly treated within this population, often resulting in career or life-threatening ramifications. Furthermore, VTE risk rises with increasing age (> 40 years), potentially affecting masters athletes. A 44-year-old well-trained male cyclist volunteered to participate in a research project investigating the influence of exercise on haemostasis in well-trained athletes. The cyclist presented with elevated D-Dimer levels both pre- (2251 ng/mL) and post-exercise (2653 ng/mL). The cyclist reported constant mild-pain in the left mid-calf region, with a cold tingling sensation in their left foot. Diagnosis of DVT was confirmed via a DVT squeeze test and Doppler ultrasound, with the clot located in the left popliteal vein. During the research project, the cyclist was exposed to numerous thrombogenic risk factors including travel, dehydration, prolonged sitting and exercise. The DVT in the popliteal vein may have resulted from repetitive movements associated with cycling. Additionally, hypertrophy of the gastrocnemius muscle may have impinged the vein. When diagnosing DVT within a cycling population, PVES should not be overlooked as a contributing factor.

Identifiants

pubmed: 30569423
doi: 10.1007/s11239-018-1796-x
pii: 10.1007/s11239-018-1796-x
doi:

Substances chimiques

Factor Xa Inhibitors 0
Rivaroxaban 9NDF7JZ4M3

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

301-304

Références

Eur J Vasc Surg. 1992 Nov;6(6):623-7
pubmed: 1451818
BMJ. 2003 Nov 8;327(7423):1072
pubmed: 14604926
Curr Sports Med Rep. 2004 Apr;3(2):77-83
pubmed: 14980135
Eur J Vasc Endovasc Surg. 2004 Jul;28(1):1-8
pubmed: 15177226
Thromb Haemost. 2005 Aug;94(2):463-4
pubmed: 16113841
CMAJ. 2006 Mar 14;174(6):801-9
pubmed: 16534088
J Thromb Haemost. 2007 Sep;5(9):1890-5
pubmed: 17723128
Knee Surg Sports Traumatol Arthrosc. 2009 Oct;17(10):1234-8
pubmed: 19238360
Cardiovasc Intervent Radiol. 2011 Feb;34 Suppl 2:S12-6
pubmed: 19768498
Phys Sportsmed. 2009 Dec;37(4):124-30
pubmed: 20048549
J Am Acad Orthop Surg. 2013 Feb;21(2):108-17
pubmed: 23378374
Br J Radiol. 2013 Oct;86(1030):20130284
pubmed: 23908347
Eur J Sport Sci. 2018 Apr;18(3):367-375
pubmed: 29320303
Semin Thromb Hemost. 2018 Nov;44(8):723-733
pubmed: 30286503
J Vasc Surg. 1993 Nov;18(5):760-6
pubmed: 8230561
Med Sci Sports Exerc. 1998 Aug;30(8):1205-10
pubmed: 9710858

Auteurs

Jack Kean (J)

Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Tasmania, Australia.

Ashleigh Pearton (A)

Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Tasmania, Australia.

James W Fell (JW)

Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Tasmania, Australia.

Murray J Adams (MJ)

Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Tasmania, Australia.
School of Veterinary and Life Sciences, Murdoch University, Perth, Western Australia, Australia.

Cecilia M Kitic (CM)

Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Tasmania, Australia.

Sam S X Wu (SSX)

Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Tasmania, Australia.
Department of Health and Medical Sciences, Swinburne University of Technology, Victoria, Australia.

Stephen Stone (S)

Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia.

Emma K Zadow (EK)

Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Tasmania, Australia. Emma.Zadow@utas.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH